<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04609449</url>
  </required_header>
  <id_info>
    <org_study_id>CZL-030619</org_study_id>
    <nct_id>NCT04609449</nct_id>
  </id_info>
  <brief_title>A Comparison Between Short vs. Long Biliopancreatic Limb Gastric Bypass</brief_title>
  <official_title>A Comparison Between Short vs. Long Biliopancreatic Limb Gastric Bypass: Early Outcomes of a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CARLOS ZERRWECK LOPEZ</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Tlahuac</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective study including patients submitted to RYGB (n=94) and L-RYGB (n=94) at a single&#xD;
      institution. The aim was to compare the effect on comorbidities and weight loss of a long&#xD;
      biliopancreatic limb Roux-en-Y gastric bypass (L-RYGB), compared with a standard RYGB.&#xD;
      Procedure selection was randomly assigned (1:1), and surgeries were performed, during 24&#xD;
      months (2016-2017). Weight loss, comorbidities control and nutritional status were assessed&#xD;
      at baseline and 12 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>12 months</time_frame>
    <description>Measures: Weight in kilograms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>12 months</time_frame>
    <description>Measures: Body Mass Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>12 months</time_frame>
    <description>Measures: Percent of excess weight loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>12 months</time_frame>
    <description>Measures: Percent of total weight loss</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete Diabetes Remission Rate</measure>
    <time_frame>12 months</time_frame>
    <description>Measures: No need for anti-diabetics while on glucose &lt;100 mg/dl and HbA1c% &lt;6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major early complications</measure>
    <time_frame>First 30 days</time_frame>
    <description>Measure: Rate of re-operations and re-admissions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major late complications</measure>
    <time_frame>2-12 months</time_frame>
    <description>Measure: Rate of re-operations and re-admisions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>12 months</time_frame>
    <description>Measure: serum albumin (gr/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>12 months</time_frame>
    <description>Measure: serum total proteins (gr/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>12 months</time_frame>
    <description>Measure: hemoglobin (g/dL)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">192</enrollment>
  <condition>Bariatric Surgery</condition>
  <condition>Metabolic Surgery</condition>
  <condition>Roux-en-Y Gastric Bypass</condition>
  <arm_group>
    <arm_group_label>Long biliopancreatic limb</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients submitted to long biliopancreatic limb Roux-en-Y gastric bypass.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard biliopancreatic limb</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients submitted to standard Roux-en-Y gastric bypass.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Long biliopancreatic limb Roux-en-Y gastric bypass.</intervention_name>
    <description>Long biliopancreatic limb Roux-en-Y gastric bypass.</description>
    <arm_group_label>Long biliopancreatic limb</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Roux-en-Y gastric bypass</intervention_name>
    <description>Standard Roux-en-Y gastric bypass</description>
    <arm_group_label>Standard biliopancreatic limb</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient submitted to bariatric surgery&#xD;
&#xD;
          -  All patients met the guidelines defined by the National Institutes of Health (NIH)&#xD;
             consensus: BMI equal or greater to 40kg/m2 or BMI 35 - 40 kg/m2 with some comorbidity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        â€¢Patients with incomplete surgery data sheet and those submitted to other type of bariatric&#xD;
        surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Zerrweck, MD</last_name>
    <role>Study Director</role>
    <affiliation>Head of Department. The Obesity Clinic at Hospital General Tlahuac</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Herrera, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Obesity Clinic at Hospital General Tlahuac</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital General Tlahuac</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Tlahuac</investigator_affiliation>
    <investigator_full_name>CARLOS ZERRWECK LOPEZ</investigator_full_name>
    <investigator_title>Professor and Head of Department.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

